28.22
price up icon1.04%   0.29
after-market Handel nachbörslich: 28.22
loading

Finanzdaten der Apellis Pharmaceuticals Inc-Aktie (APLS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
7.01%
178.49
166.80 212.53 196.83 199.69
Operating Expenses
15.33%
211.78
250.12 238.69 244.11 229.13
Benefits Costs and Expenses
14.88%
220.18
258.68 248.59 253.68 237.23
Costs And Expenses
14.88%
220.18
258.68 248.59 253.68 237.23
Operating Income/Loss
60.05%
-33.29
-83.33 -26.16 -47.28 -29.44
Income/Loss From Continuing Operations Before Tax
54.63%
-41.69
-91.88 -36.07 -56.85 -37.54
Income Tax Expense/Benefit
36.66%
0.466
0.341 0.286 0.592 0.114
Income/Loss From Continuing Operations After Tax
54.30%
-42.15
-92.22 -36.35 -57.45 -37.66
Net Income/Loss
54.30%
-42.15
-92.22 -36.35 -57.45 -37.66
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.46%
126.02
125.45 0.207 124.23 123.90
Diluted Average Shares
0.46%
126.02
125.45 0.207 124.23 123.90
Basic Earnings Per Share
55.41%
-0.33
-0.74 -0.29 -0.46 -0.30
Diluted Earnings Per Share
55.41%
-0.33
-0.74 -0.29 -0.46 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):